GSK's antibody drug sotrovimab works against Omicron mutations
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
The company has has 10 existing labs in India
The funds will be used to scale up existing operations and launch new products
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
Subscribe To Our Newsletter & Stay Updated